Biomarkers


Biomarkers in basic and clinical research as well as in clinical practice has become so commonplace that their presence as primary endpoints in clinical trials. Biomarkers that have been well characterized and repeatedly shown to correctly predict relevant clinical outcomes across a variety of treatments and populations; this use is entirely justified and appropriate. It is easy to imagine measurable Biological characteristics that do not correspond to patients' clinical state, or whose variations are undetectable and without effect on health. Surrogate endpoints are a small subset of well-characterized Biomarkers with well-evaluated clinical relevance. A Biomarker consistently and accurately predicts a clinical outcome, either a Benefit or harm.


    Related Conference of Biomarkers

    October 23-24, 2023

    18th World Summit on Biosensors and Bioelectronics

    Rome, Italy
    October 25-26, 2023

    14th International Conference on Smart Technologies

    Osaka, Japan
    November 15-16, 2023

    4th World Congress on Robotics and Automation

    Paris, France
    December 27-28, 2023

    4th Annual Congress on Biofuels and Biopolymers

    Vancouver, Canada
    February 08-09, 2024

    World Summit on Data Science and Machine Learning

    Madrid, Spain
    May 22-23, 2024

    11th Global Meet on Wireless and Satellite Communications

    Amsterdam, Netherlands
    July 25-26, 2024

    23rd International Conference on Big Data & Data Analytics

    Amsterdam, Netherlands

    Biomarkers Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in